MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,275,377 | +21.6% | 1,131,207 | +0.9% | 1.32% | +36.9% |
| Q2 2023 | $40,525,106 | +2.3% | 1,121,647 | +5.3% | 0.96% | +2.0% |
| Q1 2023 | $39,606,404 | +8.6% | 1,065,261 | +32.3% | 0.94% | +7.6% |
| Q4 2022 | $36,475,637 | -39.7% | 805,024 | -7.1% | 0.88% | -43.9% |
| Q3 2022 | $60,536,000 | +6.7% | 866,776 | +2.6% | 1.56% | -5.3% |
| Q2 2022 | $56,723,000 | +23.3% | 844,977 | +51.0% | 1.65% | +42.6% |
| Q1 2022 | $46,021,000 | -23.6% | 559,734 | +36.4% | 1.16% | -16.8% |
| Q4 2021 | $60,204,000 | -3.7% | 410,415 | +16.1% | 1.39% | +5.8% |
| Q3 2021 | $62,540,000 | +21.3% | 353,514 | +10.8% | 1.32% | +29.0% |
| Q2 2021 | $51,542,000 | -7.0% | 319,085 | -1.4% | 1.02% | -15.8% |
| Q1 2021 | $55,441,000 | -32.4% | 323,647 | -13.3% | 1.21% | -30.4% |
| Q4 2020 | $81,959,000 | +41.5% | 373,152 | +7.0% | 1.74% | +18.3% |
| Q3 2020 | $57,912,000 | +45.4% | 348,761 | 0.0% | 1.47% | +34.5% |
| Q2 2020 | $39,818,000 | +51.7% | 348,761 | +2.1% | 1.09% | +0.6% |
| Q1 2020 | $26,251,000 | -32.1% | 341,500 | +13.8% | 1.08% | -11.1% |
| Q4 2019 | $38,658,000 | +92.7% | 300,000 | +16.5% | 1.22% | +52.8% |
| Q3 2019 | $20,062,000 | -3.8% | 257,500 | +27.2% | 0.80% | +5.8% |
| Q2 2019 | $20,858,000 | +58.1% | 202,500 | +12.5% | 0.76% | +48.3% |
| Q1 2019 | $13,194,000 | +107.4% | 180,000 | +20.0% | 0.51% | +69.7% |
| Q4 2018 | $6,363,000 | -43.7% | 150,000 | -37.5% | 0.30% | -26.7% |
| Q3 2018 | $11,304,000 | -4.5% | 240,000 | 0.0% | 0.41% | -10.1% |
| Q2 2018 | $11,832,000 | +103.9% | 240,000 | +27.0% | 0.46% | +83.5% |
| Q1 2018 | $5,802,000 | +76.6% | 189,000 | +5.0% | 0.25% | +66.4% |
| Q4 2017 | $3,285,000 | – | 180,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |